Screener
Arcus Biosciences RCUS Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Operating expenses: | ||||
| Research and development (Includes $2, $11, $2 and $6 from a related party) | 113 | 139 | 235 | 261 |
| General and administrative(Includes $—, $2, $— and $2 from a related party) | 24 | 29 | 53 | 57 |
| Total operating expenses | 137 | 168 | 288 | 318 |
| Loss from operations | (96) | (8) | (230) | (130) |
| Non-operating income (expense): | ||||
| Interest and other income, net | 8 | 10 | 17 | 21 |
| Interest expense | (3) | (2) | (6) | (3) |
Item 1. Financial Statements
FAQ
- What is Arcus Biosciences's total operating expenses?
- Arcus Biosciences (RCUS) reported total operating expenses of $137M in Q2 2026.
- How has Arcus Biosciences's total operating expenses changed year-over-year?
- Arcus Biosciences's total operating expenses decreased by 18.5% year-over-year, from $168M to $137M.
- What is the long-term trend for Arcus Biosciences's total operating expenses?
- Over 4 years (2021 to 2025), Arcus Biosciences's total operating expenses has grown at a 17.8% compound annual growth rate (CAGR), from $329M to $633M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.
Ask your AI about Arcus Biosciences's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude